Kiromic BioPharma, Inc. (KRBP) DCF Valuation

Kiromic BioPharma, Inc. (KRBP) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Kiromic BioPharma, Inc. (KRBP) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Evaluate Kiromic BioPharma, Inc. (KRBP) financial outlook like an expert! This (KRBP) DCF Calculator provides pre-filled financials along with the flexibility to modify revenue growth, WACC, margins, and other essential assumptions to align with your predictions.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -3.6 -19.0 -25.7 -32.5 -16.3 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 .2 .5 2.1 2.8 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -3.7 -19.2 -26.2 -34.6 -19.1 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 1.9 10.2 25.4 .6 3.2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .5 .7 2.2 7.3 2.1 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.3 -1.5 -1.9 -4.9 -.2 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % -1.65 -1.65 -1.65 -1.65 -1.65 -1.65 -1.65 -1.65 -1.65 -1.65
EBITAT -3.7 -19.2 -26.3 -38.0 -19.4 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -3.5 -20.2 -26.2 -35.7 -22.0 -2.1 .0 .0 .0 .0
WACC, % 5.01 5.01 5.01 5.01 5.01 5.01 5.01 5.01 5.01 5.01
PV UFCF
SUM PV UFCF -2.0
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -2
Net Debt 12
Equity Value -14
Diluted Shares Outstanding, MM 1
Equity Value Per Share -13.09

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real KRBP financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Modify forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Quickly observe the effects of your inputs on Kiromic BioPharma's valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • Comprehensive Data: Kiromic BioPharma's (KRBP) historical financial reports and projected forecasts included.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and EBITDA margins to fit your analysis.
  • Real-Time Calculations: Instantly view the intrinsic value of Kiromic BioPharma (KRBP) as it updates live.
  • Intuitive Visualizations: Dashboard graphs present valuation outcomes and essential metrics clearly.
  • Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.

How It Works

  • Download: Obtain the pre-built Excel file containing Kiromic BioPharma's (KRBP) financial data.
  • Customize: Modify projections, including revenue growth, EBITDA %, and WACC.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time.
  • Test Scenarios: Develop various projections and analyze outcomes instantly.
  • Make Decisions: Leverage the valuation results to inform your investment strategy.

Why Choose Kiromic BioPharma's Calculator?

  • Precision: Utilizes real Kiromic BioPharma financials for reliable data accuracy.
  • Adaptability: Built to allow users to easily test and adjust inputs as needed.
  • Efficiency: Eliminate the complexity of constructing a DCF model from the ground up.
  • Expert-Level: Crafted with the precision and usability expected by CFOs.
  • Intuitive: Designed for ease of use, even for those without extensive financial modeling skills.

Who Should Use This Product?

  • Professional Investors: Develop comprehensive and accurate valuation models for assessing investment opportunities in Kiromic BioPharma, Inc. (KRBP).
  • Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within the organization.
  • Consultants and Advisors: Offer clients precise valuation insights for Kiromic BioPharma, Inc. (KRBP) stock.
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech companies like Kiromic BioPharma, Inc. (KRBP) are valued in the marketplace.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Kiromic BioPharma historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Kiromic BioPharma, Inc. (KRBP).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.